New sustained-release antihypertensive selected as government-funding R&D project

The Small and Medium Business Administration recently announced that a new sustained-release antihypertensive, which has been co-developed by Kolmar Korea and DDSTech, was selected as one of the government-funding R&D projects.

The SMBA noted that a total of 356 million won will be injected to the development of new sustained-release antihypertensive for two years and of the investment invo...